1 BTC
=
- USD
First Trust Capital Strength ETF
As of June 27, 2026 at 06:45 UTC
Chart
About First Trust Capital Strength ETF
No description available.
FTCS in Bitcoin terms
First Trust Capital Strength ETF is available in Roxom Terminal as an ETF page for investors who want to evaluate global market exposure without leaving a Bitcoin-denominated workflow.
- ETF pages expand Roxom's searchable global-market surface beyond single companies.
- BTC-denominated charting makes the ETF comparable to Bitcoin and other assets in the terminal.
- Related market hubs help users move from a specific ETF to broader BTC-priced markets.
Market Statistics
Trading Metrics
How to Buy FTCS
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy FTCS
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesFirst Trust Canada announced the cap (17.23% gross), buffer (10%), and dates (May 19, 2026 – May 21, 2027) for the next Target Outcome Period of the MAYB.F ETF. The fund, managed by Vest Financial LLC, seeks to provide returns matching the S&P 500 up to a cap while buffering against losses.
Walkner Condon Financial Advisors LLC increased its holding in First Trust Capital Strength ETF (FTCS) by 41,581 shares worth $3.84 million in Q4 2025, making it the firm's 10th-largest holding at 2.26% of AUM. The ETF tracks well-capitalized U.S. companies and has delivered 7% returns over the past year with lower volatility than the S&P 500.
Ergawealth Advisors sold 81,378 shares of the First Trust Capital Strength ETF (FTCS) for approximately $7.52 million in the fourth quarter. The sale reflects investor shift away from defensive equity strategies toward higher-yielding investments, as FTCS gained only 7% over the past year, trailing the S&P 500 by about 7 percentage points. The fund manager also reduced exposure to other defensive funds while increasing allocation to income-focused ETFs.
Dover reported mixed Q1 results, with revenue slightly missing estimates but adjusted EPS beating. The company lowered its 2025 EPS guidance, leading to a premarket stock decline. Dover noted strength in secular-growth markets like single-use biopharma components, thermal connectors, and CO2 systems.
